Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

The health of women and girls is closely tied to their right to make informed decisions about sexuality, marriage, and... See more
To address the food deserts throughout many of New York City’s low-income communities, the Laurie M. Tisch Illumination... See more
The United States health system falls short, bluntly declares the Commonwealth Fund in its recent report, “Mirror,... See more
Do we have a right to health care? The United States remains the only developed country in the world unable to come to... See more
Marijuana is now legal for medical purposes in 29 states, and nine states allow it to be sold for recreational use.... See more
Visionary architects, artists, and builders are using cutting-edge design to transform homes, workplaces, schools,... See more

Pages